From: A genetic interaction of NRXN2 with GABRE, SYT1 and CASK in migraine patients: a case-control study
Interaction | OR | Migraine CI 95% | P-value |
---|---|---|---|
NRXN2*SYT1 | |||
rs477138*rs1732664 | 0.10 | ||
CC*TT | 1.00 | – | – |
GC*CT | 0.34 | 0.14–0.82 | 0.02 |
NRXN2*CASK | |||
rs477138*rs2244325*rs2998250 | 0.30 | ||
CC*AA*AA | 1.00 | – | – |
GG*GG*CC | 0.08 | 0.01–0.75 | 0.03 |
NRXN2*GABRE | |||
rs477138*rs1158605 | 0.001 | ||
CC*GG | 1.00 | – | – |
CG*GT | 4.78 | 1.76–12.97 | 0.002 |